Pharma Sales
Six leadership editions
The Patent Clock Is Running
Your five commercial functions each hit their KPIs. Your uptake curve tells a different story. The gap between functional performance and commercial velocity is where millions in gross profit disappear under the patent clock.
What's Changing in Your Launch Economics
Your commercial envelope. Your uptake curve. The portfolio story against your LoE cliff. Three questions that look separate, but are actually one. A briefing for Commercial CFOs at European pharma affiliates.
What's Changing in How You Launch
Your uptake curves are sliding. Your senior MSLs are burning out. Your signal-to-action cycle is stuck at quarterly. Three problems that look separate, but are actually one. A briefing for commercial-operations leaders at European pharma affiliates.
What's Changing in the Reps and MSLs You're Building
Your A-players are watching. Your MSL apprenticeship has quietly compressed. Your 2030 senior bench is being shaped by deployment decisions you were not invited to. A briefing for Chief Human Resources Officers at mid-size and specialty pharma commercial affiliates in Europe.
What's Changing on Your Launch Floor
Your uptake curve is running below plan. Your last three formulary decisions went to better-prepared competitors. Your best MSL just mentioned retirement. Three problems that look separate, but are actually one. A briefing for commercial directors at pharmaceutical affiliates.
What's Changing in the Stack You Own
Your commercial-AI budget is two instruments pretending to be one. Your HCP intelligence sits underneath a vendor layer that commoditises every upgrade cycle. Your scorecard measures rep adoption and integration backlog, and neither is the 2026 question. A briefing for commercial CTOs, Heads of Commercial Technology, and VPs Commercial Platforms at mid-sized European pharma affiliates.